Cardiovascular Complications of Hematopoietic Stem Cell Transplantation

Anne Blaes, Suma Konety, Peter Hurley

Research output: Contribution to journalReview articlepeer-review

36 Scopus citations


Survivors of hematopoietic stem cell transplant (HSCT) are at significant risk for cardiac disease and cardiac complications. While there may be cardiac complications during the acute period of HSCT, long-term survivors remain at risk for cardiovascular disease at a rate at least fourfold higher than the general population. Aggressive screening for cardiac risk factors such as diabetes, hypertension, and arrhythmias is warranted pretransplant. For those with risk factors, particularly a history of cardiovascular disease or atrial fibrillation, cardiology consultation is warranted in the pretransplantation period. Aggressive screening for cardiac risk factors such as diabetes, hypertension, and hyperlipidemia is warranted in HSCT survivors as well; early and aggressive treatment of left ventricular dysfunction is warranted. Collaboration between hematology/oncology and cardiology through a cardio-oncology clinic is an optimal way to help manage these patients.

Original languageEnglish (US)
Article number25
Pages (from-to)1-10
Number of pages10
JournalCurrent Treatment Options in Cardiovascular Medicine
Issue number4
StatePublished - Apr 1 2016

Bibliographical note

Publisher Copyright:
© 2016, The Author(s).


  • Arrhythmias
  • Cardiac complications
  • Congestive heart failure
  • Stem cell transplantation
  • Survivors


Dive into the research topics of 'Cardiovascular Complications of Hematopoietic Stem Cell Transplantation'. Together they form a unique fingerprint.

Cite this